THE EFFICACY AND DRUG SURVIVAL OF THE BIOSIMILAR INFLIXIMAB (CT-P13) COMPARED TO THE ORIGINAL REFERENCE INFLIXIMAB IN INFLAMMATORY RHEUMATIC DISEASES; RESULTS FROM THE TURKBIO REGISTRY


Creative Commons License

Uslu S., Can G., Senel S., DALKILIÇ H. E., Inanc N., Akar S., ...Daha Fazla

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.329, (Özet Bildiri) identifier